Rare diseases Pediatrics Bone diseases Interactive e-learning

Rare bone disease e-learning

Assoc. Prof. Marelise Eekhoff

Assoc. Prof. Marelise Eekhoff
Prof. Dr Oliver Semler

Prof. Dr Oliver Semler
Prof. Eric Rush

Prof. Eric Rush
Dr Kassim Javaid

Dr Kassim Javaid
Ms. Charlene Waldman

Ms. Charlene Waldman
Ms. Inês Alves

Ms. Inês Alves
Dr Zulf Mughal

Dr Zulf Mughal
Publication Date

Nov 2021

download Downloadable resources

We recently developed a summary of the rare bone disease highlights from ASBMR 2021. Over a series of four podcasts, international experts summarised the key rare bone disease abstracts and discussed potential implications for clinical practice. An accredited e-learning is now available, access the module today to gain 1 CME credit.

 

This educational programme is supported by an Independent Educational Grant from Ipsen, Kyowa Kirin and Ultragenyx.

Prof. Eric Rush has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Alexion, AstraZeneca Rare Disease, Ultragenyx, BioMarin, Inozyme, Ipsen, Aruvant, Ascendis, Intercept, Spectrum

Programme summary
Take the e-learning now
Share this programme
x-twitter
This educational programme is supported by an Independent Educational Grant from Ipsen, Kyowa Kirin and Ultragenyx
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen, Kyowa Kirin and Ultragenyx
Accreditation
EACCME
This course has been accredited by EACCME® for ECMEC®.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

video Video
Bone diseases 
Rethinking hypophosphatasia (HPP) diagnosis and disease burden

Uncovering the clues to HPP in clinical practice

Experts
Dr Chad Deal
  • clock 11 MIN
  • calendar Jun 2025
COR2ED
This programme has been initiated and funded by Alexion Pharmaceuticals and is intended for healthcare professionals only.  The Alexion logo is a registered trademark of Alexion Pharmaceuticals, Inc.©2024 Alexion Pharmaceuticals, Inc. All rights reserved. GL/UNB-H/0069
animated-video Animated Video
Endocrinology Rare diseases Bone diseases 
Rethinking hypophosphatasia (HPP) and systemic impacts of deficient alkaline phosphatase activity

Understanding the mechanism of disease of hypophosphatasia

  • clock 4 MIN
  • calendar May 2025
COR2ED
This programme has been initiated and funded by Alexion Pharmaceuticals and is intended for healthcare professionals only.  The Alexion logo is a registered trademark of Alexion Pharmaceuticals, Inc.©2024 Alexion Pharmaceuticals, Inc. All rights reserved.GL/UNB-H/0063 – May 2025  
other Other
Bone diseases 
Rethinking hypophosphatasia (HPP): New perspectives on diagnosis and disease burden

View 5 fact cards to reveal key statistics and clinical insights on the diagnosis and disease burden of HPP in children and adults. Will they make you rethink HPP diagnosis and disease burden?

  • download Downloadable
    Resources
  • clock 1 MIN
  • calendar Feb 2025
COR2ED
This programme has been initiated and funded by Alexion Pharmaceuticals and is intended for healthcare professionals only.
podcast Podcast
Endocrinology Rare diseases Pediatrics 
Short-stature conditions, including SPIGFD

Pediatric endocrinologists discuss patient cases and share insights on clinical practice 

Experts
Prof. Andrew Dauber, Dr Marta Ramón Krauel
Endorsed by
The Magic Foundation
  • download Downloadable
    Resources
  • clock 24 MIN
  • calendar Dec 2024
PE CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Ipsen.
podcast Podcast
Oncology Rare diseases  Patient Support
Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments

Experts
Dr Mohid S Khan, Sally Jenkins
Endorsed by
CommNETs
NANETS
Neuroendocrine Cancer UK
The Healing NET Foundation
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Sep 2024
NET CONNECT Non-accredited Independent Medical Education Patient Support
Educational programme supported by an Independent Educational Grant from Ipsen
micro-learning Micro learning
Oncology Endocrinology Rare diseases 
Tools for optimising treatment & management of advanced NETs

Maximising outcomes for patients with advanced neuroendocrine tumours 

Experts
Prof. Emily Bergsland, Prof. Louis de Mestier
Endorsed by
NANETS
Neuroendocrine Cancer UK
CommNETs The Healing NET Foundation
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jul 2024
NET CONNECT GI CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Ipsen.
Explore all programmes